Study of bone marrow environment in childhood leukemia
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at what the bone marrow “microenvironment” is like in children newly diagnosed with acute leukemia, to better understand the disease. It also compares leukemia samples to samples from children having certain orthopedic surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a child age 1 to 15
- If you have leukemia: it must be newly diagnosed, not relapsed
- You must not have had any prior blood/heart-blood leukemia treatment
- Both parents (or the legal decision-maker) must sign the informed consent
- You must be able to take part in the planned bone marrow testing (no reason you can’t have it)
- You must be covered by a French social security plan (or eligible as a beneficiary)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a special blood test that measures cell-free DNA (tiny pieces of genetic material) in children with acute lymphoblastic leukemia (ALL). It aims to understand how this test might help monitor the disease, and it is for newly diagnosed children who haven't started treatment yet.
This study looks at natural killer (NK) cells, a type of immune cell, in patients with acute leukemia or myelodysplastic syndrome who are getting a stem cell transplant. It aims to understand how these cells change over time and may help predict outcomes.
This trial looks at blood and bone marrow samples from children and teens whose leukemia has come back or is hard to treat. The goal is to better understand the disease and guide future options for these patients.
This study looks at whether a simple blood test can help track how well treatment is working in children with leukemia. It may help doctors understand the disease better and guide future care.
This study looks at the gut microbiome (tiny organisms in the gut) and metabolome (small chemicals in the body) in children and teens with newly diagnosed ALL. It may help researchers understand what is happening in the body early in treatment and could guide future, more personalized care.
This trial looks at how childhood, teen, and young adult acute myeloid leukemia (AML) changes at the genetic level and how cells respond to multiple drugs. It may help doctors understand which treatments work best and how leukemia interacts with supportive cells in the bone marrow.
Hear when a new Acute Lymphoid Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.